Page 75 - Škrgat, Sabina, ed. 2023. Severe Asthma Forum - Monitoring and Treatable Traits in Severe Asthma. Koper: University of Primorska Press. Severe Asthma Forum, 2

wide Portuguese consensus. Pulmonolo- 75
gy. 2021 Jul-Aug;27(4):313-27.
48. Khurana S, Brusselle GG, Bel EH et mon i tor i ng a n d eva luat ion of t h e r a peu t ic r e sponse i n pat i e n ts w i t h sev e r e a st h m a on biologic s
al. Long-term Safety and Clinical Ben-
efit of Mepolizumab in Patients With
the Most Severe Eosinophilic Asthma:
The COSMEX Study. Clin Ther. 2019
Oct;41(10):2041-56.e5.
49. Jain KK. Role of Biomarkers in Person-
alized Medicine. In: Jain KK. Textbook
of Personalized Medicine. Cham, Swit-
zerland: Springer;2021. p. 110-13.
50. Wangberg H, Woessner K. Choice of
biologics in asthma endotypes, Curr
Opin Allergy Clin Immunol. 2021 Feb
1;21(1):79-85
51. McCracken JL, Tripple JW, Calhoun
WJ. Biologic therapy in the manage-
ment of asthma. Curr Opin Allergy
Clin Immunol. 2016 Aug;16(4):375-82.